NDC 73309-136 - Tiopronin Base
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-136
- Package NDCs from labels
- 73309-136-01, 73309-136-02, 73309-136-03, 73309-136-04
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2021-08-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tiopronin Base - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2021-08-23 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-136-01 | Tiopronin Base | 500 g in 1 JAR | POWDER | 500 | 3 | |
| 73309-136-02 | Tiopronin Base | 25000 g in 1 DRUM | POWDER | 25000 | 3 | |
| 73309-136-03 | Tiopronin Base | 1000 g in 1 JAR | POWDER | 1000 | 3 | |
| 73309-136-04 | Tiopronin Base | 100 g in 1 JAR | POWDER | 100 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Thiola | TIOPRONIN | Mission Pharmacal Company | 494a714e-923c-cd57-df6c-12886afb265a | 2026-08-27 | Warnings, Adverse reactions | C5W04GO61S |
| Tiopronin | TIOPRONIN | BioComp Pharma, Inc. | 59e06801-0ef3-29f2-e063-6294a90a4368 | 2026-08-25 | Warnings, Adverse reactions | C5W04GO61S |
| VENXXIVA | TIOPRONIN | Cycle Pharmaceuticals Ltd. | 02e24443-04c6-4b98-a395-49aec4a468de | 2025-12-22 | Warnings, Adverse reactions | C5W04GO61S |
| Thiola EC | TIOPRONIN | Mission Pharmacal Company | 20298a52-a194-a161-8632-d84b6f26e23c | 2025-10-07 | Warnings, Adverse reactions | C5W04GO61S |
| Tiopronin | TIOPRONIN | BioComp Pharma, Inc. | 1f2eb1d6-faa6-e352-e063-6294a90a7fb5 | 2025-06-05 | Warnings, Adverse reactions | C5W04GO61S |
| Tiopronin | TIOPRONIN | Teva Pharmaceuticals USA, Inc. | 8dee6eff-0ec1-4fe7-8d27-18cdc6cf54b9 | 2025-04-14 | Warnings, Adverse reactions | C5W04GO61S |
| TIOPRONIN | TIOPRONIN | Torrent Pharmaceuticals Limited | ad750031-08ec-4d92-af2d-97a80c454e14 | 2024-11-01 | Warnings, Adverse reactions | C5W04GO61S |
| TIOPRONIN | TIOPRONIN | Par Health USA, LLC | 5396b9fd-5385-44fd-a8ba-e56a46a33bc7 | 2024-10-31 | Warnings, Adverse reactions | C5W04GO61S |
| Tiopronin | TIOPRONIN | Teva Pharmaceuticals, Inc. | 749257d9-a519-4b10-9058-7fe3f301cdd2 | 2024-06-01 | Warnings, Adverse reactions | C5W04GO61S |
| tiopronin | TIOPRONIN | Amneal Pharmaceuticals NY LLC | ce5b1f97-5b3c-40b6-b1c4-1d36025be1b8 | 2023-05-01 | Warnings, Adverse reactions | C5W04GO61S |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.